PMC:7558233 / 32008-32251
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 756 | 221-226 | Gene | denotes | IFN-α | Gene:3439 |
| 785 | 29-40 | Chemical | denotes | favipiravir | MESH:C462182 |
| 786 | 196-215 | Chemical | denotes | lopinavir/ritonavir | MESH:C558899 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T192 | 0-243 | Sentence | denotes | In a pilot open-label study, favipiravir was shown to markedly shorten the time to viral clearance and increase the rate of improvement in chest imaging compared with a combination treatment with lopinavir/ritonavir plus IFN-α inhalation [89]. |